GlassScriptPhysician profile
Jin S Yoo
NPI 1811162142
$178,575.65
in general payments reported to CMS, 2019-2025
35 companies · $16K in 2025
The $16K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63K · 2020: $25K · 2021: $41K · 2022: $23K · 2023: $5,479 · 2024: $4,519 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,835 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,075 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $6,000 · Travel and Lodging: $1,371 · Consulting Fee: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,834.63 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,075.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $6,000.00 |
| Travel and Lodging | $1,371.10 |
| Consulting Fee | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $49,157.42 | 2019-2020 | |
| Medtronic, INC. | $35,541.71 | 2021-2025 | Transorb, Ligasure, Progrip |
| W. L. Gore & Associates, INC. | $30,064.76 | 2019-2024 | Gore Synecor Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Olympus America INC. | $21,227.50 | 2021 | |
| Conmed Corporation | $8,734.68 | 2019-2020 | |
| Endolumik, INC. | $6,814.67 | 2025 | Endolumik Gastric Calibration Tube, Endolumik Gastric Calibration Tube |
| Intuitive Surgical, INC. | $5,691.88 | 2019-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $3,941.99 | 2021-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Teleflex LLC | $3,024.65 | 2020-2024 | Titan Sgs, Weck |
| Applied Medical Resources Corporation | $2,880.41 | 2022 | |
| Davol INC. | $2,548.73 | 2022-2024 | Phasix Mesh |
| Allergan, INC. | $2,124.25 | 2019 | |
| Activ Surgical, INC. | $1,700.57 | 2022 | |
| Ethicon US, LLC | $997.60 | 2019-2024 | Echelon Flex, Echelon; Endopath |
| Olympus Corporation of The Americas | $870.00 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innocoll Pharmaceuticals Limited | $754.28 | 2021-2023 | Xaracoll |
| Gyrus Acmi, INC. | $491.55 | 2021 | |
| Rti Surgical, INC | $376.30 | 2023 | |
| Heron Therapeutics, INC. | $257.24 | 2023-2025 | Zynrelef |
| Stryker Corporation | $220.59 | 2019-2024 | 1788 |
| Integra Lifesciences Corporation | $190.73 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Baxter Healthcare | $182.63 | 2019 | |
| Standard Bariatrics, INC. | $178.86 | 2021 | |
| Cook Medical LLC | $151.25 | 2019 | |
| Lilly USA, LLC | $122.05 | 2024 | Zepbound |
| Abbott Laboratories | $71.89 | 2019 | |
| Tricoast Surgical Solutions LLC | $57.62 | 2024 | |
| Karl Storz Endoscopy-America | $51.50 | 2020 | |
| Levita Magnetics International Corp | $37.50 | 2019 | |
| Bolder Surgical LLC | $30.00 | 2019 | |
| Arthrex, INC. | $24.00 | 2022 | |
| Medtronic USA, INC. | $20.39 | 2020 | |
| Endo Pharmaceuticals INC. | $12.99 | 2019 | |
| Boston Scientific Corporation | $12.29 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jin Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.